Hi Tony,

Thank you very much. And you're welcome.

The results have been very promising so far, and we've only begun to scratch the surface. We'll keep mining the data and searching for other promising new hits against malaria and tuberculosis.

Cheers,
Dr. Alex L. Perryman

Hi vlado101,

You're welcome.

We have a ton of results that we still need to analyze (over a billion of them). And we need to obtain some grant funding to support the project (to pay for personnel, computers, and the compounds that we'll need to order and then test in wet lab experiments). It'll be a while before we think about starting phase 2 of the project. But there are many other projects that need your help now. Keep crunching.

Cheers,
Dr. Alex L. Perryman

Hi gb009761,

You're welcome. I'm glad that you enjoyed the abundant text. ;) You're right, there are several promising avenues that we need to explore further.

Thank you very much. Our grant applications haven't been successful yet (less than 10% of applications are funded these days). But we'll keep trying.

Best wishes,
Dr. Alex L. Perryman

Hi Erika,

Thank you very much for helping to spread the good news!

Before I sign out for the night, I need to also give special thanks to:
Maria Penzo and Professor Mike Blackman for testing the candidate compounds against PfSUB1; Weixuan Yu and Professor Peter J. Tonge for testing the first set of candidate compounds against InhA from Mycobacterium tuberculosis; and Xin Wang, Mi-Sun Koo, Pradeep Kumar, Shao-Gang Li, Steve Paget, Professor David Alland, and Associate Professor Joel S. Freundlich for testing and helping to advance the development of the second set of candidate compounds against InhA and for making the Rutgers University-New Jersey Medical School a great place to continue performing research against drug-resistant tuberculosis.

Best wishes,
Dr. Alex L. Perryman

I second that. If one can be made I would at least send it to see if maybe some funding can be brought to this project.